Northern Trust Corp Decreases Position in Azenta, Inc. (NASDAQ:AZTA)

Northern Trust Corp trimmed its holdings in shares of Azenta, Inc. (NASDAQ:AZTA) by 11.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 357,961 shares of the company’s stock after selling 47,597 shares during the period. Northern Trust Corp’s holdings in Azenta were worth $17,898,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of AZTA. Quarry LP purchased a new position in shares of Azenta in the fourth quarter worth about $110,000. Boothbay Fund Management LLC grew its position in Azenta by 8.4% during the 4th quarter. Boothbay Fund Management LLC now owns 6,571 shares of the company’s stock worth $329,000 after acquiring an additional 509 shares during the last quarter. Susquehanna Fundamental Investments LLC bought a new stake in Azenta in the fourth quarter valued at approximately $3,925,000. Lord Abbett & CO. LLC purchased a new stake in shares of Azenta during the fourth quarter valued at approximately $47,350,000. Finally, Syon Capital LLC bought a new position in shares of Azenta in the fourth quarter worth approximately $359,000. 99.08% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of equities research analysts recently commented on the stock. Evercore ISI upped their price target on shares of Azenta from $50.00 to $52.00 and gave the company an “in-line” rating in a report on Thursday, February 6th. Needham & Company LLC decreased their price objective on shares of Azenta from $59.00 to $40.00 and set a “buy” rating on the stock in a research report on Wednesday, May 7th. Finally, TD Cowen raised shares of Azenta to a “hold” rating in a research note on Thursday, February 27th.

Azenta Stock Performance

Shares of AZTA stock opened at $27.90 on Wednesday. The firm has a market cap of $1.27 billion, a P/E ratio of -9.36 and a beta of 1.64. The business’s 50 day moving average price is $30.94 and its 200-day moving average price is $41.85. Azenta, Inc. has a fifty-two week low of $23.91 and a fifty-two week high of $63.58.

Azenta (NASDAQ:AZTA) last released its quarterly earnings results on Wednesday, May 7th. The company reported $0.05 earnings per share for the quarter, missing the consensus estimate of $0.09 by ($0.04). Azenta had a negative net margin of 24.91% and a positive return on equity of 1.25%. The firm’s revenue was up 5.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.06 earnings per share. As a group, equities analysts predict that Azenta, Inc. will post 0.53 EPS for the current year.

Azenta Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.